Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19883898rdf:typepubmed:Citationlld:pubmed
pubmed-article:19883898lifeskim:mentionsumls-concept:C0006983lld:lifeskim
pubmed-article:19883898lifeskim:mentionsumls-concept:C0243026lld:lifeskim
pubmed-article:19883898lifeskim:mentionsumls-concept:C0559546lld:lifeskim
pubmed-article:19883898lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:19883898pubmed:issue7lld:pubmed
pubmed-article:19883898pubmed:dateCreated2009-11-3lld:pubmed
pubmed-article:19883898pubmed:abstractTextThyonamides are widely used drugs to treat hyperthyroidism, because of their efficacy and security. However, although with less frequency, they can cause hepatic and haemathologic toxicity. Neutropenia produced for this kind of drugs, can be very serious, to such an extent it may jeopardize patient's life. If it appears, it is necessary to stop the antithyroid treatment and, if the patient have fever or agranulocytosis, start wide spectrum antibiotics and definitive treatment with radioiodine or surgery. A file case report of a 26-years-old woman with a thyrotoxicosis secondary to Graves' disease in treatment with carbimazole. She suffered a serious sepsis, as a consequence of the drug induced neutropenia.lld:pubmed
pubmed-article:19883898pubmed:languagespalld:pubmed
pubmed-article:19883898pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19883898pubmed:citationSubsetIMlld:pubmed
pubmed-article:19883898pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19883898pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19883898pubmed:statusMEDLINElld:pubmed
pubmed-article:19883898pubmed:issn1575-0922lld:pubmed
pubmed-article:19883898pubmed:authorpubmed-author:GuardiolaPatr...lld:pubmed
pubmed-article:19883898pubmed:authorpubmed-author:TenreiroAlma...lld:pubmed
pubmed-article:19883898pubmed:issnTypePrintlld:pubmed
pubmed-article:19883898pubmed:volume56lld:pubmed
pubmed-article:19883898pubmed:ownerNLMlld:pubmed
pubmed-article:19883898pubmed:authorsCompleteYlld:pubmed
pubmed-article:19883898pubmed:pagination378-80lld:pubmed
pubmed-article:19883898pubmed:meshHeadingpubmed-meshheading:19883898...lld:pubmed
pubmed-article:19883898pubmed:meshHeadingpubmed-meshheading:19883898...lld:pubmed
pubmed-article:19883898pubmed:meshHeadingpubmed-meshheading:19883898...lld:pubmed
pubmed-article:19883898pubmed:meshHeadingpubmed-meshheading:19883898...lld:pubmed
pubmed-article:19883898pubmed:meshHeadingpubmed-meshheading:19883898...lld:pubmed
pubmed-article:19883898pubmed:meshHeadingpubmed-meshheading:19883898...lld:pubmed
pubmed-article:19883898pubmed:meshHeadingpubmed-meshheading:19883898...lld:pubmed
pubmed-article:19883898pubmed:articleTitle[A serious adverse effect: sepsis due to carbimazole].lld:pubmed
pubmed-article:19883898pubmed:affiliationHospital Infanta Sofía, Madrid, España. patricia.diaz.guardiola@gmail.comlld:pubmed
pubmed-article:19883898pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19883898pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:19883898pubmed:publicationTypeCase Reportslld:pubmed